Valuation: G MEDPAR

Market Cap 723K 632K 580K 541K 1.03M 68.83M 1.04M 6.98M 2.71M 33.76M 2.71M 2.66M 116M P/E 2021
-1.29x
P/E 2022 -0.17x
Enterprise Value 2.52M 2.2M 2.02M 1.89M 3.57M 240M 3.64M 24.35M 9.44M 118M 9.46M 9.26M 405M EV / Sales 2021
4.92x
EV / Sales 2022 1.15x
Free-Float
-
Yield 2021 *
-
Yield 2022 -
1 day-99.00%
1 month-99.00%
6 months-99.50%
Current year-99.50%
1 month 0
Extreme 0
0
Current year 0
Extreme 0
0
1 year 0
Extreme 0
0.03
3 years 0
Extreme 0
0.39
5 years 0
Extreme 0
235.9
10 years 0
Extreme 0
235.9
Manager TitleAgeSince
Chief Executive Officer 75 02/10/2014
Director of Finance/CFO 46 30/07/2022
Chief Tech/Sci/R&D Officer 56 30/11/2017
Director TitleAgeSince
Director/Board Member 75 02/10/2014
Chairman 72 20/08/2014
Director/Board Member 76 23/02/2017
Date Insider Type Main position Quantity % Market Cap.
30/03/23
AWM Investment Co., Inc.
SellCompany 737,500 37.5554%
30/03/23
AWM Investment Co., Inc.
OtherCompany 1,437,500 73.2011%

Financials

2021 2022
Net sales 5.06M 4.42M 4.06M 3.78M 7.18M 482M 7.3M 48.87M 18.94M 236M 18.99M 18.58M 814M 4.42M 3.86M 3.55M 3.31M 6.27M 421M 6.38M 42.7M 16.55M 206M 16.6M 16.24M 711M
Net income -14.76M -12.9M -11.84M -11.04M -20.94M -1.4B -21.29M -143M -55.26M -689M -55.41M -54.21M -2.37B -13.52M -11.81M -10.85M -10.12M -19.18M -1.29B -19.5M -131M -50.62M -631M -50.77M -49.67M -2.18B
Net Debt 2.41M 2.1M 1.93M 1.8M 3.42M 229M 3.47M 23.26M 9.02M 112M 9.04M 8.85M 387M 1.8M 1.57M 1.44M 1.34M 2.55M 171M 2.59M 17.36M 6.73M 83.91M 6.75M 6.6M 289M
Logo G MEDPAR
G Medical Innovations Holdings Ltd. is a mobile health (mHealth) and e-health company. The Company is focused on the development of mHealth and telemedicine solutions and monitoring service platforms. It develops and markets clinical and consumer medical-grade health monitoring solutions and offers end-to-end support for e-health projects. Its product lines consist of its Prizma medical device, a clinical grade device that can transform any smartphone into a medical monitoring device enabling both healthcare providers and individuals to monitor, manage and share a wide range of vital signs and biometric indicators and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiography data continuously, including its QT Prolongation Syndrome Detection Capabilities Patch. Its monitoring services include the provision of independent diagnostic testing facilities and private monitoring services. It also develops wireless vital signs monitoring systems.
Employees
84
Sector
-
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. GMVDF Stock